FDA issued a Warning Letter to Novel Laboratories, Inc. d.b.a LUPIN on 06/11/2021 for a previous inspection.
483 Novel Labs d.b.a Lupin Somerset Mar 2022

483 Novel Labs d.b.a Lupin Somerset Mar 2022

Sandra Boyd FDA, Adetutu Gidado FDA, Ko Min FDA$119.00 - Available Now

FDA investigators audited the Novel Labs d.b.a Lupin Somerset - Somerset, NJ, United States facility and issued inspectional observations (via FDA 483) on 30 Mar 2022.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Mar 2022
  • Location: Somerset, United States
  • FEI: 3006271438
Add To Cart